Charles Schwab’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-3,275
| Closed | -$15K | – | 3114 |
|
|
2016
Q2 | $15K | Sell |
3,275
-15,119
| -82% | -$69.2K | ﹤0.01% | 3094 |
|
|
2016
Q1 | $104K | Sell |
18,394
-16,912
| -48% | -$95.6K | ﹤0.01% | 2987 |
|
|
2015
Q4 | $608K | Buy |
35,306
+944
| +3% | +$16.3K | ﹤0.01% | 2558 |
|
|
2015
Q3 | $726K | Sell |
34,362
-11,279
| -25% | -$238K | ﹤0.01% | 2493 |
|
|
2015
Q2 | $2.26M | Buy |
45,641
+10,783
| +31% | +$534K | ﹤0.01% | 2011 |
|
|
2015
Q1 | $2.73M | Buy |
34,858
+1,639
| +5% | +$128K | ﹤0.01% | 1888 |
|
|
2014
Q4 | $2.01M | Sell |
33,219
-2,213
| -6% | -$134K | ﹤0.01% | 2008 |
|
|
2014
Q3 | $1.51M | Buy |
35,432
+9,540
| +37% | +$407K | ﹤0.01% | 2115 |
|
|
2014
Q2 | $1.6M | Buy |
25,892
+1,877
| +8% | +$116K | ﹤0.01% | 2094 |
|
|
2014
Q1 | $1.56M | Buy |
24,015
+2,001
| +9% | +$130K | ﹤0.01% | 2064 |
|
|
2013
Q4 | $1.24M | Buy |
22,014
+1,947
| +10% | +$110K | ﹤0.01% | 2169 |
|
|
2013
Q3 | $1.27M | Buy |
20,067
+1,885
| +10% | +$119K | ﹤0.01% | 2100 |
|
|
2013
Q2 | $1.1M | Buy |
+18,182
| New | +$1.1M | ﹤0.01% | 2106 |
|